Mo (@mopunjwani) unfollowed @breadfrom on Sep 28, 2024

In the new model we significantly improved accents. During the live demo you could have noticed a thick American accent. Release model feels more native for many languages. There is still a lot we can improve, give it a try and let me know how it feels.

Advanced voice model is finally rolling out this week. Post-training this model was an amazing project to work on as I transform from a CV researcher into a truly multimodal one. Join the team if you are excited to figure out the best interfaces for intelligence.

here's how I am applying the recurring pattern of material thickness to the bed frame (still wip) https://t.co/fb0pWAhyWB

currently on a mission to make a piece of furniture for every room in the house that reuses the same pattern of joinery, door handles, material proportions so far the desk, the credenza, the wardrobe, the library... now working on the bed frame https://t.co/UkkOFK83Wk https://t.co/5Oqd4uOQb1

5 steps to achieving thoughtful surgical growth: 1️⃣ Develop your strategy 2️⃣ Leverage machine learning and artificial intelligence 3️⃣ Engage with surgeon offices 4️⃣ Maximize your high-value assets 5️⃣ Fill every white space with the right surgical case https://t.co/yourAtWNA6

We're at #Intuitive360! Come find us at our booth in the IntegratEd Space to speak with our team about improving OR utilization, maximizing your robotic program, and leveraging market insights to strategically grow referrals and case volume. https://t.co/irbAjQBpuL

RT @muddywatersre: Here's a fun one - the @NYSE proposal to deal w/ systemic fraud from China issuers is to add an "indicator" to the end o…

We're in good company on @IVP's "Health AI 35: What to know, who to watch". Thanks for including SmarterDx in the provider category! Check out the full list: https://t.co/wGZKyL5bn5 https://t.co/KasbL165pA

RT @ACDIS: Have you registered yet for today’s free webinar at 1 p.m. EST diving into the #CDIWeek2024 Industry survey results, sponsored b…

Press release: https://t.co/KNVz6d1tEZ

Exciting news! We’ve secured Phase II funding for our #SubtleSYNTH™ technology to expand into brain imaging. Fresh off FDA clearance for spine STIRs, we’re pushing the boundaries of #AI in medical imaging. Stay tuned for more advancements! Read the PR in comments! #MRI https://t.co/9RJSg0UIhu

@calleymeans @thefoodbabe @jordanbpeterson @JillianMichaels @ChrisPalmerMD @maxlugavere @yoalexrapz @MikhailaFuller @realfoodology @MartyMakary @humankarp @CaseyMeansMD @travelinggenes

Full four-hour roundtable: https://t.co/FpOq5BMxNF

A few words on my former colleagues: @miramurati was my role model and a courageous leader - she gave me my best piece of management advice to date (make the decision that is fair, not the one that makes people happy). @bobmcgrewai was the best problem solver I've worked with

While today’s departures are tough, I’m incredibly excited and honored to lead research at @OpenAI alongside @merettm. I truly believe that OpenAI is the best place to work on AI, and I've been through enough ups and downs to know it's never wise to bet against us.

We're live blogging from The Hill. Get real-time updates from @crsevern himself! #pricetransparency @HouseCommerce https://t.co/kkx8246h7M

Today our very own @crsevern will be testifying in front of Congress for the @HouseCommerce. Freak out with us and watch him live, here: https://t.co/qDXaLOtU2q #pricetransparency

Joining a panel of thought leaders at the World Medical Innovation Forum today in Boston, CEO Jo Viney @76viney will discuss her insights on new disruptive approaches to treat inflammatory diseases. #WMIF2024 #SeismonautsIn Action https://t.co/J4LB4kro0v

We're delighted to welcome Julie Eastland to the Seismic Board of Directors as Independent Director. Her more than 30 years of experience in biotech finance and strategy will be important as we advance our first candidates into the clinic. #WeAreSeismic https://t.co/vkzuLrR6be https://t.co/BrYD1cssgo

I showed this to my coworker and he goes ‘nope. Ugly’ yeah that’s my 13th reason

damn https://t.co/VxQtC5fF43

RT @CaseyMeansMD: Today is my 37th birthday. Yesterday I went to the US senate and spoke my truth - as a physician, as a woman, and a livin…

RT @1053thefan: Giants writer @DDuggan21 on Malik Nabers, New York's plan of attack vs. #Cowboys, and more with @inthemageors and @OThankKe…

Let's do it. Toughest week yet! • Elevations: FB Jakob Johnson, CB Duke Shelley* (wild card prediction, thinking his experience at corner gives him the edge over Art Green) • Inactives: QB Tommy DeVito, OL Jake Kubas, OLB Benton Whitley, OLB Boogie Basham, CB Adoree' Jackson,

RT @kwharrison13: What a f*cking ambitious slide. I love it. Put this right into my veins. https://t.co/fM823fsEMW

"Experimental ARR" needs to be the new "adjusted EBITDA." There are companies that are generating $100M+ ARR but 75%+ of their revenue is coming from companies that are far from committed to productizing the use case. They're experimenting. What happens when those go away?